Literature DB >> 20338766

Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies.

Bojan Burja1, Tamara Cimbora-Zovko, Sanja Tomić, Tihana Jelusić, Marijan Kocevar, Slovenko Polanc, Maja Osmak.   

Abstract

A series of pyrazolone-fused combretastatins and precursors were synthesized and their cytotoxicity as well as antitubulin potential was evaluated. The hydrazide 9f and the pyrazolone-fused combretastatins 12a, 12b and 12c were highly cytotoxic against various tumor cell lines including cisplatin resistant cells. The same compounds were also the best inhibitors of tubulin polymerization. Molecular modeling results showed that they bind the colchicine binding site at the tubulin heterodimer. The hydrazide 9f arrested HeLa cells in the G2/M phase of the cell cycle and strongly affected cell shape and microtubule network. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338766     DOI: 10.1016/j.bmc.2010.03.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity.

Authors:  Qile Xu; Huan Qi; Maolin Sun; Daiying Zuo; Xuewei Jiang; Zhiyong Wen; Zhiwei Wang; Yingliang Wu; Weige Zhang
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

2.  Design, synthesis and biological evaluation of a series of new resveratrol analogues as potential anti-cancer agents.

Authors:  Lifang Yang; Xuemei Qin; Hongcun Liu; Yanye Wei; Hailiang Zhu; Mingguo Jiang
Journal:  R Soc Open Sci       Date:  2019-09-04       Impact factor: 2.963

3.  Ultrasound-promoted two-step synthesis of 3-arylselenylindoles and 3-arylthioindoles as novel combretastatin A-4 analogues.

Authors:  Zhiyong Wen; Xiaona Li; Daiying Zuo; Binyue Lang; Yang Wu; Mingyang Jiang; Huizhuo Ma; Kai Bao; Yingliang Wu; Weige Zhang
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

4.  Discovery of 'click' 1,2,3-triazolium salts as potential anticancer drugs.

Authors:  Ivana Steiner; Nikolina Stojanovic; Aljosa Bolje; Anamaria Brozovic; Denis Polancec; Andreja Ambriovic-Ristov; Marijana Radic Stojkovic; Ivo Piantanida; Domagoj Eljuga; Janez Kosmrlj; Maja Osmak
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.